Rigel Pharmaceuticals (RIGL) Posts Wider than Expected Q4 Loss of 36c/Share
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $48.82 +3.67%
EPS Growth %: -34.9%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -34.9%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q4 EPS of ($0.36), $0.08 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Talos Energy closes $420M Gulf of America deepwater asset deal
- Societe Generale SA (GLE:FP) (SCGLY) PT Raised to EUR83 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
